Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
33,560
archived clinical trials in
Neurology

Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University Hospital Case Medical Center (Surgical)
mi
from
Cleveland, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University Hospital Case Medical Center (Surgical)
mi
from
Cleveland, OH
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Moss Rehab (Assessment)
mi
from
Elkins Park, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Alabama at Birmingham (Surgical/Assessment)
mi
from
Birmingham, AL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Alabama at Birmingham (Surgical/Assessment)
mi
from
Birmingham, AL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Xenoscience, Inc. (Assessment)
mi
from
Phoenix, AZ
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Xenoscience, Inc. (Assessment)
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Ronald Reagan UCLA Medical Center (Assessment/Surgical)
mi
from
Los Angeles, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Ronald Reagan UCLA Medical Center (Assessment/Surgical)
mi
from
Los Angeles, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of California Irvine (Assessment)
mi
from
Orange, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of California Irvine (Assessment)
mi
from
Orange, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Providence Saint John's Health Center (Assessment)
mi
from
Santa Monica, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Providence Saint John's Health Center (Assessment)
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Providence St. John's Health Center (Surgical)
mi
from
Santa Monica, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Providence St. John's Health Center (Surgical)
mi
from
Santa Monica, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Stanford Health Care (Surgical/Assessment)
mi
from
Stanford, CA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
New England Institute for Clinical Research (Assessment)
mi
from
Stamford, CT
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Miami Miller School of Medicine (Assessment/Surgical)
mi
from
Miami, FL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Miami Miller School of Medicine (Assessment/Surgical)
mi
from
Miami, FL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Grady Memorial Hospital (Assessment)
mi
from
Atlanta, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Grady Memorial Hospital (Assessment)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Emory University Hospital (Surgical)
mi
from
Atlanta, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Center for Advanced Research and Education (Assessment)
mi
from
Gainesville, GA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Center for Advanced Research and Education (Assessment)
mi
from
Gainesville, GA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Chicago Medical Center (Assessment)
mi
from
Chicago, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Chicago Medical Center (Assessment)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Chicago Medical Center (Surgical)
mi
from
Chicago, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Chicago Medical Center (Surgical)
mi
from
Chicago, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Consultants in Neurology, Ltd. (Assessment)
mi
from
Northbrook, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Consultants in Neurology, Ltd. (Assessment)
mi
from
Northbrook, IL
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Kansas Medical Center (Surgical)
mi
from
Kansas City, KA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Kansas Medical Center (Surgical)
mi
from
Kansas City, KA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Kentucky Hospital (Surgical)
mi
from
Lexington, KY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Kentucky Hospital (Surgical)
mi
from
Lexington, KY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Louisville Clinical Trials Unit (Assessment)
mi
from
Louisville, KY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Louisville Clinical Trials Unit (Assessment)
mi
from
Louisville, KY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Beth Israel Deaconess Medical Center (Surgical)
mi
from
Boston, MA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Beth Israel Deaconess Medical Center (Surgical)
mi
from
Boston, MA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Wayne State University (Assessment)
mi
from
Detroit, MI
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Wayne State University (Assessment)
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Henry Ford Health System (Assessment)
mi
from
Detroit, MI
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Henry Ford Health System (Assessment)
mi
from
Detroit, MI
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Rutgers New Jersey Medical School (Assessment)
mi
from
Newark, NJ
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Rutgers New Jersey Medical School (Assessment)
mi
from
Newark, NJ
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
New York University Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
New York University Langone Medical Center (Surgical/Assessment)
mi
from
New York, NY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
The Burke Rehabilitation Hospital (Assessment)
mi
from
White Plains, NY
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
The Burke Rehabilitation Hospital (Assessment)
mi
from
White Plains, NY
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Carolinas Rehabilitation (Assessment)
mi
from
Charlotte, NC
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Carolinas Rehabilitation (Assessment)
mi
from
Charlotte, NC
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Toledo Medical Center (Assessment)
mi
from
Toledo, OH
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Toledo Medical Center (Assessment)
mi
from
Toledo, OH
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Hospital of the University of Pennsylvania (Assessment)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Hospital of the University of Pennsylvania (Assessment)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Pennsylvania Hospital (Surgical)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Pennsylvania Hospital (Surgical)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Thomas Jefferson University Comprehensive Stroke Center (Assessment)
mi
from
Philadelphia, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Thomas Jefferson University Comprehensive Stroke Center (Assessment)
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Pittsburgh Medical Center (Surgical/Assessment)
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Abington Neurological Associates (Assessment)
mi
from
Willow Grove, PA
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Abington Neurological Associates (Assessment)
mi
from
Willow Grove, PA
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Medical University of South Carolina (Surgical)
mi
from
Charleston, SC
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Chattanooga Center for Neurologic Research (Assessment)
mi
from
Chattanooga, TN
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Chattanooga Center for Neurologic Research (Assessment)
mi
from
Chattanooga, TN
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
University of Texas Health Science Center at Houston (Assessment/Surgical)
mi
from
Houston, TX
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
University of Texas Health Science Center at Houston (Assessment/Surgical)
mi
from
Houston, TX
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
West Virginia University Hospitals (Assessment)
mi
from
Morgantown, WV
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
West Virginia University Hospitals (Assessment)
mi
from
Morgantown, WV
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
MedStar National Rehabilitation Hospital (Assessment)
mi
from
Washington,
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
MedStar National Rehabilitation Hospital (Assessment)
mi
from
Washington,
Click here to add this to my saved trials
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated:  11/3/2017
Northwestern Memorial Hospital (Surgical)
mi
from
Chicago, IL
Study of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
A Double-Blind, Controlled Phase 2b Study of the Safety and Efficacy of Modified Stem Cells (SB623) in Patients With Chronic Motor Deficit From Ischemic Stroke
Status: Enrolling
Updated: 11/3/2017
Northwestern Memorial Hospital (Surgical)
mi
from
Chicago, IL
Click here to add this to my saved trials
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Status: Enrolling
Updated:  11/3/2017
Program in Physical Therapy, Washington University in St. Louis
mi
from
Saint Louis, MO
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Effect of Weight-Bearing Exercise on People With Diabetes and Neuropathic Feet
Status: Enrolling
Updated: 11/3/2017
Program in Physical Therapy, Washington University in St. Louis
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated:  11/3/2017
Tower Orthopaedics
mi
from
Beverly Hills, CA
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated: 11/3/2017
Tower Orthopaedics
mi
from
Beverly Hills, CA
Click here to add this to my saved trials
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated:  11/3/2017
Yale University School of Medicine
mi
from
New Haven, CT
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated: 11/3/2017
Yale University School of Medicine
mi
from
New Haven, CT
Click here to add this to my saved trials
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated:  11/3/2017
Research Medical Center
mi
from
Kansas City, MO
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated: 11/3/2017
Research Medical Center
mi
from
Kansas City, MO
Click here to add this to my saved trials
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated:  11/3/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Comparison of Cervical Laminectomy to Laminoplasty
Comparison of Cervical Laminectomy to Cervical Laminoplasty* in Patients With Cervical Myelopathy or Myeloradiculopathy Due to Multiple Level Cervical Spinal Canal Stenosis * ARCH™ Fixation System by SYNTHES
Status: Enrolling
Updated: 11/3/2017
Washington University School of Medicine
mi
from
Saint Louis, MO
Click here to add this to my saved trials
Nuedexta for the Treatment of Adults With Autism
Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder
Status: Enrolling
Updated:  11/4/2017
Sutter Pediatric Neurology
mi
from
Sacramento, CA
Nuedexta for the Treatment of Adults With Autism
Nuedexta for Neurobehavioral Symptoms of Adults With Autism Spectrum Disorder
Status: Enrolling
Updated: 11/4/2017
Sutter Pediatric Neurology
mi
from
Sacramento, CA
Click here to add this to my saved trials
Sex Differences in Vascular Markers of Stroke Risk
Sex Differences in Vascular Markers of Stroke Risk
Status: Enrolling
Updated:  11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Sex Differences in Vascular Markers of Stroke Risk
Sex Differences in Vascular Markers of Stroke Risk
Status: Enrolling
Updated: 11/6/2017
Wake Forest University Health Sciences
mi
from
Winston-Salem, NC
Click here to add this to my saved trials
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated:  11/6/2017
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 11/6/2017
Huntington Medical Research Institutes
mi
from
Pasadena, CA
Click here to add this to my saved trials
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated:  11/6/2017
HMRI
mi
from
Pasadena, CA
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 11/6/2017
HMRI
mi
from
Pasadena, CA
Click here to add this to my saved trials
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated:  11/6/2017
Molecular Neurology Program
mi
from
Pasadena, CA
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Multimodal Approach to Testing the Acute Effects of Mild Traumatic Brain Injury (mTBI)
Status: Enrolling
Updated: 11/6/2017
Molecular Neurology Program
mi
from
Pasadena, CA
Click here to add this to my saved trials
Ramelteon and Citicoline for Delirium
A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population
Status: Enrolling
Updated:  11/7/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Ramelteon and Citicoline for Delirium
A Feasibility Study of Ramelteon and Citicoline for Delirium in a General Inpatient Hospital Population
Status: Enrolling
Updated: 11/7/2017
UT Southwestern Medical Center
mi
from
Dallas, TX
Click here to add this to my saved trials